<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03269630</url>
  </required_header>
  <id_info>
    <org_study_id>LSU</org_study_id>
    <nct_id>NCT03269630</nct_id>
  </id_info>
  <brief_title>New Orleans Pulmonary Hypertension Biobank</brief_title>
  <acronym>NO-PH Biobank</acronym>
  <official_title>New Orleans Pulmonary Hypertension Biobank</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Louisiana State University Health Sciences Center in New Orleans</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Louisiana State University Health Sciences Center in New Orleans</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pulmonary hypertension (PH) is a serious condition characterized by a mean pulmonary artery
      pressure &gt;=25mmHg on right heart catheterization (RHC). Despite advances in PH care, outcomes
      are still sub-optimal and further research is required into the pathobiology of the disease
      and development of biomarkers that can guide clinical care. The investigators are
      establishing a biobank to collect samples (blood, urine, stool) from patients with pulmonary
      hypertension, patients at high risk for pulmonary hypertension, healthy controls, and
      patients undergoing right heart catheterization. Specimens will be stored for future
      investigations.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 29, 2017</start_date>
  <completion_date type="Anticipated">October 2027</completion_date>
  <primary_completion_date type="Anticipated">October 2027</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Collection of biospecimens</measure>
    <time_frame>10 years</time_frame>
    <description>Biospecimen collection only</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">450</enrollment>
  <condition>Pulmonary Hypertension</condition>
  <condition>Systemic Sclerosis</condition>
  <condition>Mixed Connective Tissue Disease</condition>
  <condition>Heart Failure With Normal Ejection Fraction</condition>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Clinic patients (Comprehensive Pulmonary Hypertension Center)</arm_group_label>
    <description>Pulmonary hypertension patients (WHO group 1-5)
Systemic sclerosis patients without pulmonary hypertension
Mixed connective tissue disease patients without pulmonary hypertension</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Outpatient right heart catheterization patients</arm_group_label>
    <description>-Outpatients undergoing right heart catheterization for any indication</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy controls</arm_group_label>
    <description>Age&gt;18
Not actively smoking
No chronic medical conditions</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention. Biospecimen collection only</intervention_name>
    <description>Biospecimen collection</description>
    <arm_group_label>Clinic patients (Comprehensive Pulmonary Hypertension Center)</arm_group_label>
    <arm_group_label>Outpatient right heart catheterization patients</arm_group_label>
    <arm_group_label>Healthy controls</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood (serum, plasma, buffy coat, PBMCs) Urine Stool
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects will be enrolled from 2 venues: 1) Comprehensive Pulmonary Hypertension Center
        clinic (pulmonary hypertension, systemic sclerosis without PH, mixed connective tissue
        disease without PH) and 2) Outpatient right heart catheterization lab. Healthy subjects
        (age&gt;18, not currently smoking, no chronic medical conditions) will also be enrolled.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of pulmonary hypertension and followed at the Comprehensive Pulmonary
             Hypertension Center OR

          -  Diagnosis of systemic sclerosis and followed at the Comprehensive Pulmonary
             Hypertension Center OR

          -  Diagnosis of mixed connective tissue disease and followed at the Comprehensive
             Pulmonary Hypertension Center OR

          -  Undergoing outpatient right heart catheterization

        Exclusion Criteria:

          -  Age&lt;18

          -  Pregnant

          -  Unable to understand English

          -  Currently incarcerated

          -  Unwilling or unable to sign informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Matthew R Lammi, MD, MSCR</last_name>
    <phone>5045684634</phone>
    <email>mlammi@lsuhsc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Medical Center-New Orleans</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew Lammi, MD, MSCR</last_name>
      <phone>504-568-4634</phone>
      <email>mlammi@lsuhsc.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 29, 2017</study_first_submitted>
  <study_first_submitted_qc>August 30, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 1, 2017</study_first_posted>
  <last_update_submitted>January 11, 2018</last_update_submitted>
  <last_update_submitted_qc>January 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Louisiana State University Health Sciences Center in New Orleans</investigator_affiliation>
    <investigator_full_name>Matthew Lammi</investigator_full_name>
    <investigator_title>Associate Professor of Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Hypertension, Pulmonary</mesh_term>
    <mesh_term>Scleroderma, Systemic</mesh_term>
    <mesh_term>Scleroderma, Diffuse</mesh_term>
    <mesh_term>Connective Tissue Diseases</mesh_term>
    <mesh_term>Mixed Connective Tissue Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>A sharing plan will be developed to share biospecimens with interested researchers.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

